Dr. Joy Tara Aden, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5000 Schertz Pkwy, Suite 100, Schertz, TX 78154 Phone: 210-650-9978 Fax: 210-650-5975 |
Sheemain Asaria, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5000 Schertz Pkwy Ste 100, Schertz, TX 78154 Phone: 210-650-9978 |
Dr. Bruce Donald Akright, M.D. Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5000 Schertz Pkwy, Suite 100, Schertz, TX 78154 Phone: 210-650-9978 Fax: 210-650-5975 |
Dr. Randall Kent Sadler, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5000 Schertz Pkwy, Suite 100, Schertz, TX 78154 Phone: 210-650-9978 Fax: 210-650-5975 |
Dr. Jean-anthony P Do, MD Obstetrics & Gynecology - Obstetrics Medicare: Accepting Medicare Assignments Practice Location: 5000 Schertz Pkwy, Suite 100, Schertz, TX 78154 Phone: 210-650-9978 Fax: 210-650-5975 |
Dr. Joseph Anthony Garza, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5000 Schertz Pkwy, Suite 100, Schertz, TX 78154 Phone: 210-650-9978 Fax: 210-650-5975 |
News Archive
The U.S. Food and Drug Administration and the National Institutes of Health today, as part of an on-going interagency partnership, have awarded a total of up to $53 million to fund tobacco-related research in fiscal year 2013 to create 14 Tobacco Centers of Regulatory Science.
The Oklahoma Board of Medical Licensure and Supervision has launched two new online services providing simple government transactions for the medical community.
Infectious disease scientists from Novartis, the University of Georgia and Washington State University have reported the discovery and early validation of a drug candidate for treating cryptosporidiosis, a diarrheal disease which is a major cause of child mortality in lower-income countries. Currently there are no vaccines or effective treatments.
Sound and vibration expert, Bruel & Kjaer UK has added a new training course to its 2020 calendar, providing delegates with a variety of optional acoustic and vibration sessions over three days.
Blood offers promise as a way to detect Alzheimer's disease at its earliest onset, Mayo Clinic researchers say. They envision a test that would detect distinct metabolic signatures in blood plasma that are synonymous with the disease - years before patients begin showing cognitive decline.
› Verified 8 days ago